Dhanuka Agritech (DHANUKA)
CyclicalFairStock Score: 18/100 — RISKY
Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,009.7 |
| Market Cap | ₹4,501.07 Cr |
| P/E Ratio | 16.98 |
| ROCE | 28.29% |
| ROE | 20.84% |
| Dividend Yield | 0.2% |
| Profit Growth | -34.6% |
| Debt/Equity | 0.02 |
| Sales Growth | -13.87% |
| Promoter Holding | 69.71% |
| 52-Week Range | ₹889.6 — ₹1,620.4 |
| Sector | Fertilizers & Agrochemicals |
| Book Value | ₹373.12 |
Strengths
- Almost zero debt with Debt/Equity of 0.02, giving financial flexibility during a downturn
- Strong historical profitability with ROE of 20.84% and ROCE of 28.29%
- High promoter holding of 69.71%, aligning management with minority shareholders
- Established agrochemical franchise that has consistently generated high capital returns
Concerns
- Sales declined 7.94% and profit declined 27.33%, showing clear fundamental deterioration
- Piotroski F-Score of 3/9 points to worsening financial health and operating efficiency
- Valuation remains rich at P/E of 17.27 and P/B of 3.77 despite falling earnings
- FairStock Score of 21/100 flags the stock as risky
AI Analysis
Looking at Dhanuka Agritech, I see a business with a strong balance sheet but falling earnings. A 20.84% return on equity and 28.29% return on capital employed tell me that, historically, this has been a high-quality franchise. Debt is almost nil at 0.02 times equity, and promoters own 69.71%, so their interests are aligned with mine. Yet I must be honest: the recent numbers are not encouraging. Sales are down 7.94% and profit is down 27.33%. The latest quarter, ₹410 crore in sales and ₹40 crore in net profit, shows the business is still generating cash, but the trend is my concern. The Piotroski F-Score is just 3 out of 9, which suggests the financial health is deteriorating, not improving. And despite this weakness, the market is asking for ₹1,070 per share, roughly 17.27 times earnings and 3.77 times book value of ₹283.63. That is not a Graham-style margin of safety. I would rather own a mediocre business at a wonderful price than a good business at a poor price. With a dividend yield of only 0.20%, shareholders are not being paid to wait. Agrochemicals are cyclical; farmer demand, seasonality, and pricing pressure can all hurt profitability. This may be a temporary down-cycle, but I have no special ability to call the turn. The FairStock Score of 21/100 reinforces the risky setup. I will wait for concrete evidence of recovery: positive sales growth, stable margins, and an improving F-Score. Until then, my answer is simple: observe, don't invest.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer